Cancer Therapeutics (CT) Program
The goal of the Cancer Therapeutics (CT) Program is to foster the development
of novel therapeutic, chemopreventive and biomarker strategies that can
be translated into more effective clinical applications through proof-of-principle,
early-phase clinical and correlative science studies.
The thematic areas and specific aims of the CT Program are:
- Drug Development and Delivery: To foster the development and enhanced delivery
of new therapeutic and preventive agents.
- Biomarkers: To promote discovery and utilization of biomarkers that can
be used for diagnosis, prognosis and prediction of response.
- Developmental Therapeutics: To design and conduct innovative early-phase
clinical trials integrated with correlative science studies.
VIEW PROGRAM MEMBERS